Giorgia Guglielmi
The abundance of Bifidobacterium may explain M116’s excellent cholesterol profile and low inflammation levels.
The authors propose a coordinated framework involving policymakers, scientists, educators, and communities to embed microbiota science into One Health strategies.
Targeting gut bacteria or butyrate could be a promising therapy for glioma.
Dietary fiber during early life protects fertility by supporting healthy gut microbes and preventing ovarian damage caused by high-fat diets.
Gut microbes could be a target for preventing kidney disease-related heart failure.
Restoring beneficial bacteria could lead to new treatments for chronic pain in people with sickle cell disease.
Gut microbes can interact with genetics and hormone metabolism to influence pregnancy outcomes.
Combining data about gut-brain–related disorders with genetic and other information provides a powerful approach for predicting Alzheimer’s and Parkinson’s disease.
The findings of a news study reveal how Bifidobacterium evolve and adapt to different hosts, paving the way for targeted therapies such as customized probiotics and diet-based interventions.
Three promising bacteria were linked to better treatment responses in melanoma patients.
